Global Celiac Disease Market Research Report 2023

Report ID: 1900848 | Published Date: Sep 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Distension
        1.2.3 Diarrhea
        1.2.4 Anorexia
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Celiac Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Celiac Disease Market Perspective (2017-2028)
    2.2 Celiac Disease Growth Trends by Region
        2.2.1 Celiac Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Celiac Disease Historic Market Size by Region (2017-2022)
        2.2.3 Celiac Disease Forecasted Market Size by Region (2023-2028)
    2.3 Celiac Disease Market Dynamics
        2.3.1 Celiac Disease Industry Trends
        2.3.2 Celiac Disease Market Drivers
        2.3.3 Celiac Disease Market Challenges
        2.3.4 Celiac Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Celiac Disease Players by Revenue
        3.1.1 Global Top Celiac Disease Players by Revenue (2017-2022)
        3.1.2 Global Celiac Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Celiac Disease Revenue
    3.4 Global Celiac Disease Market Concentration Ratio
        3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2021
    3.5 Celiac Disease Key Players Head office and Area Served
    3.6 Key Players Celiac Disease Product Solution and Service
    3.7 Date of Enter into Celiac Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Breakdown Data by Type
    4.1 Global Celiac Disease Historic Market Size by Type (2017-2022)
    4.2 Global Celiac Disease Forecasted Market Size by Type (2023-2028)
5 Celiac Disease Breakdown Data by Application
    5.1 Global Celiac Disease Historic Market Size by Application (2017-2022)
    5.2 Global Celiac Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Celiac Disease Market Size (2017-2028)
    6.2 North America Celiac Disease Market Size by Country (2017-2022)
    6.3 North America Celiac Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Celiac Disease Market Size (2017-2028)
    7.2 Europe Celiac Disease Market Size by Country (2017-2022)
    7.3 Europe Celiac Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Celiac Disease Market Size (2017-2028)
    8.2 Asia-Pacific Celiac Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Celiac Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Celiac Disease Market Size (2017-2028)
    9.2 Latin America Celiac Disease Market Size by Country (2017-2022)
    9.3 Latin America Celiac Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Celiac Disease Market Size (2017-2028)
    10.2 Middle East & Africa Celiac Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Celiac Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Celiac Disease Introduction
        11.1.4 Roche Revenue in Celiac Disease Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Celiac Disease Introduction
        11.2.4 Merck Revenue in Celiac Disease Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Celiac Disease Introduction
        11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 BiolineRx
        11.4.1 BiolineRx Company Detail
        11.4.2 BiolineRx Business Overview
        11.4.3 BiolineRx Celiac Disease Introduction
        11.4.4 BiolineRx Revenue in Celiac Disease Business (2017-2022)
        11.4.5 BiolineRx Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Detail
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Celiac Disease Introduction
        11.5.4 Pfizer Revenue in Celiac Disease Business (2017-2022)
        11.5.5 Pfizer Recent Development
    11.6 Innovate Biopharmaceuticals
        11.6.1 Innovate Biopharmaceuticals Company Detail
        11.6.2 Innovate Biopharmaceuticals Business Overview
        11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction
        11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2017-2022)
        11.6.5 Innovate Biopharmaceuticals Recent Development
    11.7 ImmusanT
        11.7.1 ImmusanT Company Detail
        11.7.2 ImmusanT Business Overview
        11.7.3 ImmusanT Celiac Disease Introduction
        11.7.4 ImmusanT Revenue in Celiac Disease Business (2017-2022)
        11.7.5 ImmusanT Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Celiac Disease Introduction
        11.8.4 Novartis Revenue in Celiac Disease Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Detail
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Celiac Disease Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2017-2022)
        11.9.5 Bristol-Myers Squibb Recent Development
    11.10 Immunomedics
        11.10.1 Immunomedics Company Detail
        11.10.2 Immunomedics Business Overview
        11.10.3 Immunomedics Celiac Disease Introduction
        11.10.4 Immunomedics Revenue in Celiac Disease Business (2017-2022)
        11.10.5 Immunomedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Celiac Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Distension
    Table 3. Key Players of Diarrhea
    Table 4. Key Players of Anorexia
    Table 5. Key Players of Others
    Table 6. Global Celiac Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Celiac Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Celiac Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Celiac Disease Market Share by Region (2017-2022)
    Table 10. Global Celiac Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Celiac Disease Market Share by Region (2023-2028)
    Table 12. Celiac Disease Market Trends
    Table 13. Celiac Disease Market Drivers
    Table 14. Celiac Disease Market Challenges
    Table 15. Celiac Disease Market Restraints
    Table 16. Global Celiac Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Celiac Disease Market Share by Players (2017-2022)
    Table 18. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2021)
    Table 19. Ranking of Global Top Celiac Disease Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Celiac Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Celiac Disease Product Solution and Service
    Table 23. Date of Enter into Celiac Disease Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Celiac Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Celiac Disease Revenue Market Share by Type (2017-2022)
    Table 27. Global Celiac Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Celiac Disease Revenue Market Share by Type (2023-2028)
    Table 29. Global Celiac Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Celiac Disease Revenue Market Share by Application (2017-2022)
    Table 31. Global Celiac Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Celiac Disease Revenue Market Share by Application (2023-2028)
    Table 33. North America Celiac Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Celiac Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Celiac Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Celiac Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Celiac Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Celiac Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Celiac Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Celiac Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Celiac Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Celiac Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Roche Company Detail
    Table 44. Roche Business Overview
    Table 45. Roche Celiac Disease Product
    Table 46. Roche Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 47. Roche Recent Development
    Table 48. Merck Company Detail
    Table 49. Merck Business Overview
    Table 50. Merck Celiac Disease Product
    Table 51. Merck Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 52. Merck Recent Development
    Table 53. Johnson & Johnson Company Detail
    Table 54. Johnson & Johnson Business Overview
    Table 55. Johnson & Johnson Celiac Disease Product
    Table 56. Johnson & Johnson Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 57. Johnson & Johnson Recent Development
    Table 58. BiolineRx Company Detail
    Table 59. BiolineRx Business Overview
    Table 60. BiolineRx Celiac Disease Product
    Table 61. BiolineRx Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 62. BiolineRx Recent Development
    Table 63. Pfizer Company Detail
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Celiac Disease Product
    Table 66. Pfizer Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 67. Pfizer Recent Development
    Table 68. Innovate Biopharmaceuticals Company Detail
    Table 69. Innovate Biopharmaceuticals Business Overview
    Table 70. Innovate Biopharmaceuticals Celiac Disease Product
    Table 71. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 72. Innovate Biopharmaceuticals Recent Development
    Table 73. ImmusanT Company Detail
    Table 74. ImmusanT Business Overview
    Table 75. ImmusanT Celiac Disease Product
    Table 76. ImmusanT Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 77. ImmusanT Recent Development
    Table 78. Novartis Company Detail
    Table 79. Novartis Business Overview
    Table 80. Novartis Celiac Disease Product
    Table 81. Novartis Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Development
    Table 83. Bristol-Myers Squibb Company Detail
    Table 84. Bristol-Myers Squibb Business Overview
    Table 85. Bristol-Myers Squibb Celiac Disease Product
    Table 86. Bristol-Myers Squibb Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 87. Bristol-Myers Squibb Recent Development
    Table 88. Immunomedics Company Detail
    Table 89. Immunomedics Business Overview
    Table 90. Immunomedics Celiac Disease Product
    Table 91. Immunomedics Revenue in Celiac Disease Business (2017-2022) & (US$ Million)
    Table 92. Immunomedics Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Celiac Disease Market Share by Type: 2021 VS 2028
    Figure 2. Distension Features
    Figure 3. Diarrhea Features
    Figure 4. Anorexia Features
    Figure 5. Others Features
    Figure 6. Global Celiac Disease Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Celiac Disease Report Years Considered
    Figure 10. Global Celiac Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Celiac Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Celiac Disease Market Share by Region: 2021 VS 2028
    Figure 13. Global Celiac Disease Market Share by Players in 2021
    Figure 14. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2021
    Figure 16. North America Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Celiac Disease Market Share by Country (2017-2028)
    Figure 18. United States Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Celiac Disease Market Share by Country (2017-2028)
    Figure 22. Germany Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Celiac Disease Market Share by Region (2017-2028)
    Figure 30. China Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Celiac Disease Market Share by Country (2017-2028)
    Figure 38. Mexico Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Celiac Disease Market Share by Country (2017-2028)
    Figure 42. Turkey Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Celiac Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Roche Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 45. Merck Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 47. BiolineRx Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 49. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 50. ImmusanT Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 53. Immunomedics Revenue Growth Rate in Celiac Disease Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Frequently Asked Questions
Celiac Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Celiac Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Celiac Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports